Methods for determining breast cancer and melanoma by assaying f

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 912, 435 72, 435 724, 536 235, 536 2431, 536 2433, C12Q 168, C12P 1934, C07H 2104

Patent

active

061400505

ABSTRACT:
The invention relates to assays for determining breast cancer or melanoma. It has been found that the accuracy of such assays can be improved by assaying samples for three or more known tumor rejection antigen precursors. For breast cancer, the tumor rejection antigen precursors known as SCP-1, NY-ESO-1, and SSX-2 are assayed. For melanoma, SSX-2, NY-ESO-1, and MAGE-3 are assayed. Additional known tumor rejection antigen precursors can also be determined to confirm the assays. It is preferred to carry these out via polymerase chain reactions.

REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
patent: 5571711 (1996-11-01), Van der Bruggen et al.
patent: 5610013 (1997-03-01), Van den Eynde et al.
patent: 5612201 (1997-03-01), De Plaen et al.
patent: 5648226 (1997-07-01), Van den Eynde et al.
patent: 5698396 (1997-12-01), Pfreundschuh
patent: 5888751 (1999-03-01), Tureci et al.
Chen et al. Proceedings of the National Academy of Sciences. 94:1914-1918, Mar. 1997.
Tureci et al., "Identificaion of a Meiosis-Specific Protein as a Member of the Class of Cancer/Testis Antigen" Proc. Natl. Acad. Sci. USA, 95:5211-5216 (1998).
Tureci et al., "The SSX-2 Gene, Which is Involved in the t(X;18) Translocation of Synovial Sarcomas, Codes for the Human Tumor Antigen HOM-MEL.sup.1 ", Cancer Research, 56:4766-4772 (1996).
Tureci et al., "Expression of SSX Genes in Human Tumors", Int. J. Cancer, 77:19-23 (1998).
Gure et al., "SSX: A Multigene Family with Several Members Transcribed in Normal Testis and Human Cancer," Int. J. Cancer, 72:965-971 (1997).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for determining breast cancer and melanoma by assaying f does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for determining breast cancer and melanoma by assaying f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for determining breast cancer and melanoma by assaying f will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2049827

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.